Total Payments
$2,898
2024 Payments
$130.43
Companies
20
Transactions
30
Medicare Patients
2,732
Medicare Billing
$530,332
Payment Breakdown by Category
Food & Beverage$2,250 (77.6%)
Travel$648.74 (22.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,250 | 28 | 77.6% |
| Travel and Lodging | $648.74 | 2 | 22.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $932.82 | 7 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $289.63 | 4 | $0 (2021) |
| Melinta Therapeutics, Inc. | $251.46 | 2 | $0 (2018) |
| VisionRT, Inc. | $146.04 | 1 | $0 (2019) |
| Celgene Corporation | $135.64 | 1 | $0 (2017) |
| Ion Beam Applications S.A. | $127.35 | 1 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, INC. | $125.99 | 1 | $0 (2019) |
| Progenics Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2023) |
| PUMA BIOTECHNOLOGY, INC. | $124.97 | 1 | $0 (2021) |
| Jazz Pharmaceuticals Inc. | $121.06 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.43 | 3 | RefleXion Medical, Inc. ($67.67) |
| 2023 | $125.00 | 1 | Progenics Pharmaceuticals, Inc. ($125.00) |
| 2022 | $18.88 | 1 | GENZYME CORPORATION ($18.88) |
| 2021 | $1,303 | 10 | Stryker Corporation ($932.82) |
| 2019 | $479.65 | 7 | VisionRT, Inc. ($146.04) |
| 2018 | $459.19 | 5 | Melinta Therapeutics, Inc. ($251.46) |
| 2017 | $382.25 | 3 | Celgene Corporation ($135.64) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Food and Beverage | In-kind items and services | $67.67 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $37.71 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 02/09/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/03/2022 | GENZYME CORPORATION | LIBTAYO (Biological), LIBTAYO, LIBTAYO | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Oncology | ||||||
| 08/11/2021 | Stryker Corporation | NA (Device) | Travel and Lodging | Cash or cash equivalent | $600.70 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 08/08/2021 | Stryker Corporation | NA (Device) | Travel and Lodging | Cash or cash equivalent | $48.04 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 08/04/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Oncology | ||||||
| 07/31/2021 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 07/30/2021 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $144.40 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 07/27/2021 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $40.26 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 07/27/2021 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $39.36 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 07/27/2021 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 06/24/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $120.21 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2021 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Oncology | ||||||
| 09/11/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Oncology | ||||||
| 08/07/2019 | Lilly USA, LLC | ERBITUX (Drug), CYRAMZA | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Oncology | ||||||
| 07/18/2019 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $93.46 | General |
| Category: NEUROLOGY | ||||||
| 05/25/2019 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $54.23 | General |
| Category: OS | ||||||
| 04/06/2019 | VisionRT, Inc. | — | Food and Beverage | Cash or cash equivalent | $146.04 | General |
| 01/30/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $125.99 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 10/05/2018 | Melinta Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $118.76 | General |
| 10/04/2018 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | Cash or cash equivalent | $132.70 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/13/2018 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $121.06 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 634 | 1,579 | $517,377 | $116,128 |
| 2022 | 18 | 712 | 1,874 | $567,156 | $131,583 |
| 2021 | 18 | 683 | 1,695 | $564,783 | $134,696 |
| 2020 | 21 | 703 | 1,915 | $631,266 | $147,925 |
Total Patients
2,732
Total Services
7,063
Medicare Billing
$530,332
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 35 | 125 | $90,500 | $20,910 | 23.1% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 65 | 246 | $61,254 | $13,221 | 21.6% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 65 | 72 | $46,224 | $10,523 | 22.8% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 43 | 50 | $46,050 | $10,027 | 21.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 29 | 480 | $41,280 | $8,726 | 21.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 55 | 55 | $35,365 | $8,282 | 23.4% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Facility | 2023 | 13 | 14 | $37,786 | $7,904 | 20.9% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 18 | 18 | $29,034 | $6,380 | 22.0% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 52 | 201 | $25,326 | $5,842 | 23.1% |
| 77470 | Special radiation treatment | Facility | 2023 | 55 | 59 | $24,898 | $5,597 | 22.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 18 | 22 | $19,272 | $4,225 | 21.9% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 41 | 53 | $16,695 | $3,884 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 21 | $8,967 | $2,601 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 34 | $10,268 | $2,406 | 23.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 59 | 79 | $8,453 | $2,109 | 25.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $10,766 | $2,086 | 19.4% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 16 | 23 | $2,691 | $776.71 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 13 | $2,548 | $625.35 | 24.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 49 | 198 | $143,352 | $33,567 | 23.4% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 69 | 235 | $58,515 | $12,784 | 21.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2022 | 40 | 696 | $59,856 | $12,753 | 21.3% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 72 | 73 | $46,866 | $10,827 | 23.1% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 28 | 28 | $45,164 | $10,596 | 23.5% |
| 77295 | 3d radiation therapy planning | Facility | 2022 | 40 | 45 | $41,445 | $9,165 | 22.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 58 | 58 | $37,294 | $9,052 | 24.3% |
About Dr. John Lee, MD
Dr. John Lee, MD is a Radiation Oncology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316938657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lee, MD has received a total of $2,898 in payments from pharmaceutical and medical device companies, with $130.43 received in 2024. These payments were reported across 30 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,250).
As a Medicare-enrolled provider, Lee has provided services to 2,732 Medicare beneficiaries, totaling 7,063 services with total Medicare billing of $530,332. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location San Francisco, CA
- Active Since 11/04/2005
- Last Updated 12/09/2008
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1316938657
Products in Payments
- NA (Device) $932.82
- Vabomere (Drug) $132.70
- ANDEXXA (Biological) $125.99
- PYLARIFY (Drug) $125.00
- TAGRISSO (Drug) $124.98
- NERLYNX (Drug) $124.97
- VYXEOS (Drug) $121.06
- Enhertu (Drug) $120.21
- BYDUREON (Drug) $119.26
- TECFIDERA (Drug) $93.46
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $67.67
- LIBTAYO (Biological) $56.59
- SpaceOAR (Device) $50.52
- IMFINZI (Drug) $45.39
- TrueBeam (Device) $36.15
- Udenyca (Biological) $25.05
- ERBITUX (Drug) $14.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in San Francisco
Dr. David Kornguth, M.d, M.D
Radiation Oncology — Payments: $48,414
Radiation Oncology $48,414
Steve Braunstein, Md, Phd, MD, PHD
Radiation Oncology — Payments: $33,152
Radiation Oncology $33,152
Dr. Catherine Park, M.d, M.D
Radiation Oncology — Payments: $13,750
Radiation Oncology $13,750
Dr. I-Chow Hsu, M.d, M.D
Radiation Oncology — Payments: $12,707
Radiation Oncology $12,707
Dr. Encouse Golden, Md, Phd, MD, PHD
Radiation Oncology — Payments: $9,823
Radiation Oncology $9,823
Dr. Alexander Gottschalk, M.d, M.D
Radiation Oncology — Payments: $6,460
Radiation Oncology $6,460